Payne Christopher D 4
4 · Hims & Hers Health, Inc. · Filed Jun 15, 2026
Research Summary
AI-generated summary of this filing
Hims & Hers (HIMS) Director Christopher Payne Converts 14,343 RSUs
What Happened Christopher D. Payne, a director of Hims & Hers Health, converted a total of 14,343 restricted stock units (RSUs) into Class A common shares in mid‑June 2026. The Form 4 lists conversions on 2026-06-11 (3,656 RSUs) and 2026-06-15 (10,040 RSUs and 647 RSUs). The transactions are reported as derivative conversions (transaction code M) and show no cash consideration ($0) in the filing.
Key Details
- Transaction dates and amounts: 6/11/2026 — 3,656 RSUs; 6/15/2026 — 10,040 RSUs and 647 RSUs; total converted = 14,343 shares.
- Reported prices/consideration: Acquisitions listed as N/A; disposals listed at $0 (derivative conversion), indicating no cash sale recorded in the Form 4.
- Shares owned after transaction: Not specified in the filing.
- Footnotes of note:
- RSUs represent a contingent right to one share per RSU and were granted under the director compensation policy in lieu of Q1 2026 cash fees (foregone cash $14,875; grant price $22.98).
- Vesting references: service-based schedule over 3 years (1/3 vested 6/15/2025, 1/3 on 6/15/2026, 1/3 on 5/15/2027); these RSUs vested per the company’s vesting rule noted in the filing.
- Timeliness: Form filed 2026-06-15 covering transactions on 6/11 and 6/15; the filing itself does not flag lateness.
Context
- These were conversions of RSUs to shares (transaction code M). The filing shows no sale or cash proceeds — this reflects issuance/vesting/conversion of director RSUs rather than an open‑market purchase or sale. Such filings document compensation being settled in equity; they are routine for directors receiving RSU grants.
Insider Transaction Report
Form 4
Payne Christopher D
Director
Transactions
- Exercise/Conversion
Class A Common Stock
[F1]2026-06-11+3,656→ 23,631 total - Exercise/Conversion
Class A Common Stock
[F2]2026-06-15+10,040→ 33,671 total - Exercise/Conversion
Class A Common Stock
[F3]2026-06-15+647→ 34,318 total - Exercise/Conversion
Restricted Stock Unit
[F1]2026-06-11−3,656→ 0 total→ Class A Common Stock (3,656 underlying) - Exercise/Conversion
Restricted Stock Unit
[F4][F2]2026-06-15−10,040→ 10,040 total→ Class A Common Stock (10,040 underlying) - Exercise/Conversion
Restricted Stock Unit
[F4][F3]2026-06-15−647→ 0 totalFrom: 2026-06-15→ Class A Common Stock (647 underlying)
Holdings
- 110,000(indirect: By Trust)
Class A Common Stock
Footnotes (4)
- [F1]The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.
- [F2]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on May 15, 2027.
- [F3]The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date.
- [F4]The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
Signature
/s/ Kimberly Mather, Attorney-in-Fact for Christopher D Payne|2026-06-15